How to prescribe Tivicay?
Convenience beyond once-daily dosing
TIVICAY (dolutegravir) is a once-daily, unboosted integrase inhibitor indicated in combination with other anti-retroviral medicinal products for the treatment of Human Immunodeficiency Virus (HIV) infected adults, adolescents and children above 6 years of age. 1
Available tablet strengths 1
- 10 mg film-coated tablets: white, round, biconvex tablets approximately 6 mm in diameter
- 25 mg film-coated tablets: pale yellow, round, biconvex tablets approximately 7 mm in diameter
- 50 mg film-coated tablets: yellow, round, biconvex tablets approximately 9 mm in diameter
Hypersensitivity to the active substance or to any of the excipients. Co-administration with dofetilide.
For further information, please see Tivicay prescribing information
▼This medicinal product is subject to additional monitoring.
*Must be taken in combination with other antiretroviral agents. 1
**In the presence of INI class resistance, TIVICAY should preferably be taken with food to enhance exposure (particularly in patients with Q148 mutations). 1
‡In the presence of integrase inhibitor resistance, there are insufficient data to recommend a dose for dolutegravir in adolescents and children. 1